Session Datesort descending
Pediatric acute leukemia with ETV6 alterations 08/09/2023 - 12:00pm to 1:00pm CDT
Adolescent with SHH, TP53-mut Medulloblastoma: School aged male with WNT subtype (and co-occurring SHH pathway activated (passenger)) medulloblastoma 09/13/2023 - 12:00pm to 1:00pm CDT
Adolescent with thyroid follicular carcinoma and germline DICER1 variant/Adolescent with papillary thyroid carcinoma harboring NCOA4::RET fusion 10/11/2023 - 12:00pm to 1:00pm CDT
CBFA2T3-fusion AML 11/08/2023 - 12:00pm to 1:00pm CST
Toddler female with infant-type hemispheric glioma/School age female with high-grade glioma IDH-/H3-wildtype 12/13/2023 - 12:00pm to 1:00pm CST
CIC-Rearranged Sarcoma 02/14/2024 - 12:00pm to 1:00pm CST
Mesenchymal Tumors with CREB::CREM Fusion 04/10/2024 - 12:00pm to 1:00pm CDT
Targeted Therapies in Cancer Predisposition Syndromes: MEK Inhibitors in NF1, mTOR Inhibitors in TSC, HIF2a Inhibitor in VHL. 05/08/2024 - 12:00pm to 1:00pm CDT